293 References 153. Kadota K, Kushida Y, Katsuki N, et al. Tumor Spread Through Air Spaces Is an Independent Predictor of Recurrence-free Survival in Patients With Resected Lung Squamous Cell Carcinoma. Am J Surg Pathol. 2017;41(8):1077-1086. doi:10.1097/PAS.0000000000000872 154. Abdel-Wanis MES, Tsuchiya H, Kawahara N, Tomita K. Tumor growth potential after tumoral and instrumental contamination: An in-vivo comparative study of T-saw, Gigli saw, and scalpel. J Orthop Sci. 2001;6(5):424-429. doi:10.1007/s007760170009 155. Scotti V, Di Cataldo V, Falchini M, et al. Isolated chest wall implantation of non-small cell lung cancer after fine-needle aspiration: a case report and review of the literature. Tumori. 98(5):126e-129e. doi:10.1700/1190.13213 156. McDonald CF, Baird L. Risk of needle track metastasis after fine needle lung aspiration in lung cancer--a case report. Respir Med. 1994;88(8):631-632. Accessed March 23, 2018. http://www.ncbi.nlm.nih.gov/pubmed/7991890 157. Matsuguma H, Nakahara R, Kondo T, Kamiyama Y, Mori K, Yokoi K. Risk of pleural recurrence after needle biopsy in patients with resected early stage lung cancer. Ann Thorac Surg. 2005;80(6):2026-2031. doi:10.1016/j.athoracsur.2005.06.074 158. Smith BD, Kapur D, Esfahanian S, Dhami MS, Fischer JJ. Challenging problems in malignancy: case 2. Isolated needle-track recurrence following fine needle aspiration for non-small-cell lung cancer. J Clin Oncol. 2004;22(18):3828-3829. doi:10.1200/JCO.2004.11.058 159. Valle LGM, Rocha RD, Mendes GF, Succi JE, de Andrade JR. Tumor seeding along the needle track after percutaneous lung biopsy. J Bras Pneumol. 2016;42(1):71. doi:10.1590/S180637562016000000280 160. Adams RF, Gray W, Davies RJO, Gleeson F V. Percutaneous image-guided cutting needle biopsy of the pleura in the diagnosis of malignant mesothelioma. Chest. 2001;120(6):17981802. 161. Gerrand CH, Rankin K. The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. In: Classic Papers in Orthopaedics. ; 2014:491-493. doi:10.1007/978-14471-5451-8_129 162. Blaauwgeers H, Flieder D, Warth A, et al. A Prospective Study of Loose Tissue Fragments in Non–Small Cell Lung Cancer Resection Specimens. Am J Surg Pathol. 2017;41(9):1226-1230. doi:10.1097/PAS.0000000000000889 163. Persson C. Primary lysis of eosinophils in severe desquamative asthma. Clin Exp Allergy. 2014;44(2):173-183. doi:10.1111/cea.12255 164. Kamiya K, Hayashi Y, Douguchi J, et al. Histopathological features and prognostic significance of the micropapillary pattern in lung adenocarcinoma. Mod Pathol. 2008;21(8):992-1001. doi:10.1038/modpathol.2008.79 165. Zhao S, Guo T, Li J, et al. Expression and prognostic value of GalNAc-T3 in patients with completely resected small (≤2 cm) peripheral lung adenocarcinoma after IASLC/ATS/ERS classification. Onco Targets Ther. 2015;8:3143-3152. doi:10.2147/OTT.S93486 166. Trzpis M, McLaughlin PMJ, de Leij LMFH, Harmsen MC. Epithelial cell adhesion molecule: more than a carcinoma marker and adhesion molecule. Am J Pathol. 2007;171(2):386-395. doi:10.2353/ajpath.2007.070152 167. Bofin AM, Lydersen S, Hagmar BM. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast. Diagn Cytopathol. 2004;31(4):207-215. doi:10.1002/dc.20098 168. Zhan B, Lu D, Luo P, Wang B. Prognostic value of expression of microRNAs in non-small cell lung cancer: A systematic review and meta-analysis. Clin Lab. 2016;62(11):2203-2211. doi:10.7754/Clin.Lab.2016.160426 169. Zhu CQ, Shih W, Ling CH, Tsao MS. Immunohistochemical markers of prognosis in non-small cell lung cancer: A review and proposal for a multiphase approach to marker evaluation. J Clin Pathol. 2006;59(8):790-800. doi:10.1136/jcp.2005.031351 A
RkJQdWJsaXNoZXIy MTk4NDMw